Trial NCT01910441

View at ClinicalTrials.gov 
Org. Study IDs: CLAF237AIN03

Last trial update was posted on 2015-10-28

MeSH Interventions

Glimepiride Metformin Vildagliptin

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions

Type 2 Diabetes Mellitus

Stopping Reasons

The study was terminated due to the unavailability of Continuous Glucose Monitoring sensors (CGMS) which were required to assess the primary end-point.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID